Researcher
Sofie Struyf
- Disciplines:Immunology
Affiliations
- Molecular Immunology (Rega Institute) (Lab)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 30
- Identifying neutrophilic granulocytes as key contributors and therapeutic targets in the development and progression of BCR::ABL1 negative myeloproliferative neoplasms.From4 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Leukocyte trafficking in the resolution of inflammationFrom1 Oct 2023 → TodayFunding: Fund Recuperation Fiscal Exemption, BOF - projects
- Dental Tissue Regeneration via Bioengineerd Immune Modulatory Scaffolds (DREIMS)From1 Oct 2023 → TodayFunding: BOF - projects
- Training of young scientists in the Biological regulation of the chemokine network to improve treatment of ACTIVE inflammationFrom1 Sep 2023 → TodayFunding: BOF - projects
- Inhibition of lung inflammation in pneumonia induced by micro-organismsFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- The role of T- and B-cells in uveitis, and its implications for more specific targeted treatment.From12 Jul 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Understanding the role of neutrophil recruitment and activation in arboviral diseases.From1 Jan 2022 → TodayFunding: International Cooperation and Mobility
- Validation of biomarkers that can improve prediction of the outcome of immune checkpoint inhibitors.From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Post-translational modification of SAA1 in rheumatoid arthritis, fueling or dampening inflammation?From1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- The studie of the metabolic impact of ADA2 deficiencyFrom6 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 142
- Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases.(2024)
Authors: Janne Renders, Sofie Struyf
Pages: 103532 - Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity(2024)
Authors: Sam Noppen, Mieke Gouwy, Lisa Verhallen, Mirre De Bondt, Dominique Schols, Pedro Elias Marques, Sofie Struyf, Paul Proost
- A stabilized CXCL9(74-103)-derived peptide selectively inhibits proliferation, adhesion and metastasis of tumor cells that express high levels of heparan sulfate(2023)
Authors: Alexandra De Zutter, Luna Dillemans, Sam Noppen, Helena Crijns, Paulien Verscheure, Janne Verhaegen, Dominique Schols, Paul Proost, Sofie Struyf
Pages: 2808 - 2822 - CD40 Ligand-CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy(2023)
Authors: Luna Dillemans, Gert De Hertogh, Ghislain Opdenakker, Sofie Struyf
- Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders(2023)
Authors: Gert De Hertogh, Sara Salama, Ghislain Opdenakker, Sofie Struyf
- Antibodies as tools in cytokine discovery and usage for diagnosis and therapy of inflammatory diseases.(2023)
Authors: Jo Van Damme, Ghislain Opdenakker, Sofie Struyf
Pages: 1 - 9 - Role of Defensins in Tumor Biology(2023)
Authors: Lowie Adyns, Paul Proost, Sofie Struyf
- Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands(2023)
Authors: Sara Salama, Mieke Gouwy, Jo Van Damme, Sofie Struyf
Pages: 1 - 15 - A proteomic approach to better understand the role of human neutrophil peptides in the NSCLC microenvironment(2023)
Authors: Sofie Struyf
- Sputum from patients with primary ciliary dyskinesia contains high numbers of dysfunctional neutrophils and inhibits efferocytosis(2022)
Authors: Maaike Cockx, Sara Salama, Mirre De Bondt, Natalie Lorent, Mieke Gouwy, Mieke Boon, Sofie Struyf